FDA Inspection 1156030 — Adaptive Biotechnologies Corporation
The FDA completed an inspection of Adaptive Biotechnologies Corporation on October 29, 2021 in Bothell, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 29, 2021
- Fiscal Year
- 2022
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Bothell, WA (United States)